Figure 2.
Representative flow cytometric analysis of peripheral blood from NOG mice after HSC transplantation. Four weeks after the transplantation, less than 2% of the cells were human CD45, in which CD33+ myeloid cells were predominant, and CD19+ B cells and CD56+ NK cells were also present. Twelve weeks after the transplantation, more than 40% cells were replaced by human CD45+ cells, among which abundant human CD3+ T cells were identified.